Appointment of representative to Board of Autins

Braveheart Investment Group plc (AIM: BRH) announces that Dr Qu Li (Non-Executive Director of Braveheart) has been appointed as a Non-Executive Director to the Board of Autins Group plc ("Autins"). Braveheart holds 26.95% per cent. of the issued share capital of Autins and Dr Qu Li has been appointed to act as a representative of Braveheart on the Board of Autins.

As part of Dr Qu Li's appointment to the Board of Autins, Braveheart, Autins, and the nominated adviser to Autins have all entered into a relationship agreement (the "Relationship Agreement"). The Relationship Agreement is to ensure that Autins is capable of carrying on its business independently of Braveheart at all times, and that the costs associated with Qu Li's appointment and tenure as a Director of Autins will be borne by Braveheart.

Trevor Brown, CEO of Braveheart, commented:

"It is three years since we first invested in Autins. Over the ensuing months, as we got to know Autins and its Board, we became convinced that a bright future lay ahead for the company as conditions in the global automative market normalized after the shock of COVID. Qu Li has a deep knowledge of the sector built over many years and we believe that her appointment will prove beneficial to both Boards."

Duncan Vasey / Lucy Williams